Skip to main content

Your stock market edge


RNS Hotlist: May 19 Conroy Gold, Genedrive, Premier African


RNS Hotlist: May 19 Conroy Gold, Genedrive, Premier African

Conroy Gold and Natural Resources (CGNR), the gold exploration and development company,  announced that it has acquired an equity interest in AIM-quoted Karelian Diamond Resources (KDR) through entering into a debt capitalisation arrangement, including the issue of convertible loan notes, with Karelian Diamonds. Following the Investment and completion of the fundraising by Karelian Diamonds, Conroy Gold is expected to be interested in 5,000,000 KDR Shares equivalent to 5.29% of the enlarged issued share capital of Karelian Diamonds.

Comment: It may be said that the pairing up of Conroy and Karelian appears at first glance to be almost as unexpected as that between Bing Crosby and David Bowie. It is noteworthy that there is no quote regarding the deal in the RNS to explain the move.

Premier African Minerals (PREM) announced, after receiving further institutional interest following the funding announced 15 May 2023, a further placing to raise £610,000 before expenses at an issue price of 0.925 pence per new ordinary share for the ongoing Zulu Lithium and Tantalum Project Pilot Plant optimisation. George Roach, Chief Executive Officer, has agreed to participate in the placing at the Placing Price by way of a subscription of £110,000.

Comment: PREM takes advantage of the bull run in its stock, with a raise of just over £600,000. It is noteworthy that the CEO has led from the front, although given the ongoing interest in the stock, the company could have raised far more.

Genedrive (GDR), the point of care molecular diagnostics company, announced that the UK’s National Institute for Health and Care Excellence has recommended in draft guidance that CYP2C19 genotyping should be used before clopidogrel administration in the management of ischemic stroke patients. GDR said it remains focused on achieving release and UKCA approval of the Genedrive CYP2C19 ID Kit in advance of the final NICE guidance publication date.

Comment: It has generally been difficult for many companies that benefitted from the pandemic bubble to emerge successfully as conditions normalized. However, Genedrive continues to finesse its offering as the latest news from NICE underlines.

Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.



RNS Hotlist May 26: Amaroq, Chamberlin, Echo, Polarean, Prospex, Tekcapital, Touchstone, Wishbone

Wishbone Gold (WSBN), updated on programmes since the release on 27 April 2023 which highlighted significant potential in reprocessed historic…

RNS Hotlist May 25: Actual Experience, ANGLE, Drumz, Fulcrum, Panthera, Phoenix, Pires, Zinc

RECENT POSTS Pires Investments (PIRI), the investment company focused on next generation technology including AI, updated in relation to its…

RNS Hotlist May 24: Celadon, Contango, Coral, Falcon, Hydrogen Future, Future Metals, Kendrick, Lift Global, Marula

Lift Global Ventures Plc (AQSE:LFT) updated on Miriad Limited, Lift's digital financial marketing and IR consulting investee company run by…

RNS Hotlist May 23: Baron, Bradda, Canadian, Marula, Southern, Tap, URA, Wishbone

URA (URAH), a minerals exploration company, announced that it has raised £280,000 (before expenses) through a placing and subscription, issuing…